A Prospective Observational Cohort Study on Dynamic CD8+ T-cell Profiling and Multi-omics Biomarkers for Predicting Conversion Therapy Response in Unresectable Hepatocellular Carcinoma
Not yet recruitingOBSERVATIONAL
Enrollment
120
Participants
Timeline
Start Date
September 1, 2025
Primary Completion Date
August 31, 2027
Study Completion Date
August 31, 2028
Conditions
HCC - Hepatocellular Carcinoma
All Listed Sponsors
lead
Tongji Hospital
OTHER
NCT07117279 - A Prospective Observational Cohort Study on Dynamic CD8+ T-cell Profiling and Multi-omics Biomarkers for Predicting Conversion Therapy Response in Unresectable Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter